Home - Products - Cell Cycle/DNA Damage - GPR - GW 9508

GW 9508

CAS No. 885101-89-3

GW 9508( GW9508 | GW-9508 | GW 9508 )

Catalog No. M16407 CAS No. 885101-89-3

GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	28	In Stock
10MG	28	In Stock
25MG	46	In Stock
50MG	73	In Stock
100MG	133	In Stock
200MG	197	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

GW 9508
Note

Research use only, not for human use.
Brief Description

GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32.
Description

GW9508 is a potent and selective agonist for FFA1 (GPR40) with pEC50 of 7.32, 100-fold selective against GPR120, stimulates insulin secretion in a glucose-sensitive manner.
In Vitro

——
In Vivo

——
Synonyms

GW9508 | GW-9508 | GW 9508
Pathway

Cell Cycle/DNA Damage
Target

GPR
Recptor

GPR120| GPR40(FFA1)
Research Area

Metabolic Disease
Indication

——

Chemical Information

CAS Number

885101-89-3
Formula Weight

347.41
Molecular Formula

C22H21NO3
Purity

>98% (HPLC)
Solubility

Ethanol: 69 mg/mL (198.61 mM); DMSO: 69 mg/mL (198.61 mM)
SMILES

O=C(O)CCC1=CC=C(NCC2=CC=CC(OC3=CC=CC=C3)=C2)C=C1
Chemical Name

3-(4-((3-phenoxybenzyl)amino)phenyl)propanoic acid

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Briscoe CP, et al. Br J Pharmacol, 2006, 148(5), 619-628.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

PSB-CB5

PSB-CB5 (GPR18-IN-32)2 is a GRP18 antagonist with anti-inflammatory activity and can be used to study obesity and metabolic disorders.
BigLEN (rat)

Potent GPR171 agonist (EC50 = 1.6 nM). ProSAAS-derived peptide. Regulates body weight in mice and promotes the outgrowth of neurites in Neuro2A cells.
GW-1100

GW-1100 is a selective GPR40 and FFAR1 antagonist for the study of diabetes and metabolic diseases.

Sign In Join Free